Health and Healthcare

Novartis : NVS

All Novartis Articles

134 Articles

Lee Jackson | Nov 24, 2021 at 7:25 AM EST

Top Strategist Says Health Care Could Rule in 2022: 5 Dividend Winners

With the potential for far lower returns in the coming year, total return becomes a key ingredient for investment success.…

Lee Jackson | Oct 21, 2021 at 7:37 AM EDT

5 Top Goldman Sachs European Stock Picks Come With Big Dividends

These five top stocks on the Goldman Sachs European Conviction List all trade on American exchanges, have liquidity and pay…

Lee Jackson | Sep 27, 2021 at 7:27 AM EDT

5 European Dividend Aristocrats Offer Huge Income and Growth Potential

24/7 Wall St. screened the top European Dividend Aristocrats looking for the most liquid and well-known names for investors seeking…

Lee Jackson | Sep 20, 2021 at 8:48 AM EDT

Monday’s Top Analyst Upgrades and Downgrades: Adobe, Analog Devices, Colgate, Novartis, Salesforce, Workday and More

Monday's top analyst upgrades and downgrades included Adobe, Analog Devices, Big Lots, Colgate-Palmolive, Novartis, Salesforce.com and Workday.

Paul Ausick | Jun 11, 2021 at 1:27 PM EDT

4 Buy-Rated Giants Pay a Dividend of at Least 3%

Here are four companies with huge market caps that pay big dividends and have for a long time.

Chris Lange | Mar 10, 2021 at 12:41 PM EST

DraftKings, H&R Block, Novartis and More Wednesday Afternoon Analyst Calls

24/7 Wall St. looks at some big analyst calls that we have seen so far on Wednesday, including DraftKings, H&R…

Paul Ausick | Mar 31, 2020 at 1:17 PM EDT

Court Rejects Patent Protection, Crushing Amarin Stock

Until late Monday, Amarin continued to get good news relevant to Vascepa, its treatment for cardiovascular disease. The big news,…

Chris Lange | Mar 30, 2020 at 10:54 AM EDT

Big Pharma Advances on COVID-19

24/7 Wall St. has tracked some health care companies with prospects at crafting a vaccine to deal with this novel…

Jon C. Ogg | Feb 25, 2020 at 9:05 AM EST

Top Analyst Upgrades and Downgrades: Aurora Cannabis, Biogen, Micron, Nio, Nvidia, Palo Alto, Tandem Diabetes, Tesla and More

Tuesday's top analyst upgrades, downgrades and initiations included Aurora Cannabis, Biogen, EverQuote, Micron Technology, Nio, Nvidia, Palo Alto Networks, Tandem…

Lee Jackson | Feb 11, 2020 at 7:15 AM EST

5 Big Dividend Pharmaceutical Stocks to Buy as Health Care Could Explode Higher

24/7 Wall St. screened the Merrill Lynch health care research database looking for large pharmaceutical leaders that also pay solid…

Chris Lange | Nov 25, 2019 at 10:02 AM EST

Novartis Finally Comes Through With Its Acquisition of Medicines Co

Medicines Co shares shot up on Monday after it was reported that Novartis will be acquiring the firm. The transaction…

Chris Lange | Nov 19, 2019 at 10:40 AM EST

Will Medicines Co Be the Next Target of Novartis?

Medicines shares shot up on Tuesday after it was reported that Novartis might be eyeing this company as its newest…

Jon C. Ogg | Feb 6, 2019 at 8:55 AM EST

Top Analyst Upgrades and Downgrades: DowDuPont, Electronic Arts, Estee Lauder, Exxon, Generac, Match, Nasdaq, Novartis, PayPal, Snap, Vishay and More

The top analyst upgrades, downgrades and initiations seen on Wednesday included DowDuPont, Electronic Arts, Estee Lauder, Exxon, Generac, Match, Nasdaq,…

Chris Lange | Dec 18, 2018 at 1:40 PM EST

Why Tilray Is Booming

Tilray shares made a solid gain on Tuesday after the company announced that it entered a global agreement to collaborate…

Jon C. Ogg | Nov 19, 2018 at 9:00 AM EST

Top Analyst Upgrades and Downgrades: American Air, BlackBerry, Mallinkrodt, PG&E, RingCentral, Southwest Airlines, Yeti and More

Stocks were indicated to open lower on Monday after weekend news that sounds like a China trade deal is…

1 2 3 4 … 9

Novartis : NVS

All Novartis Articles

Top Strategist Says Health Care Could Rule in 2022: 5 Dividend Winners

5 Top Goldman Sachs European Stock Picks Come With Big Dividends

5 European Dividend Aristocrats Offer Huge Income and Growth Potential

Monday’s Top Analyst Upgrades and Downgrades: Adobe, Analog Devices, Colgate, Novartis, Salesforce, Workday and More

4 Buy-Rated Giants Pay a Dividend of at Least 3%

DraftKings, H&R Block, Novartis and More Wednesday Afternoon Analyst Calls

Court Rejects Patent Protection, Crushing Amarin Stock

Big Pharma Advances on COVID-19

Top Analyst Upgrades and Downgrades: Aurora Cannabis, Biogen, Micron, Nio, Nvidia, Palo Alto, Tandem Diabetes, Tesla and More

5 Big Dividend Pharmaceutical Stocks to Buy as Health Care Could Explode Higher

Novartis Finally Comes Through With Its Acquisition of Medicines Co

Will Medicines Co Be the Next Target of Novartis?

Top Analyst Upgrades and Downgrades: DowDuPont, Electronic Arts, Estee Lauder, Exxon, Generac, Match, Nasdaq, Novartis, PayPal, Snap, Vishay and More

Why Tilray Is Booming

Top Analyst Upgrades and Downgrades: American Air, BlackBerry, Mallinkrodt, PG&E, RingCentral, Southwest Airlines, Yeti and More

‘Convert $100,000 a Year to Get Them to the Top of the 22%’: The Roth Plan for a Couple With $2.3M in 401(k)s

UFO ETF Faces a Critical Test: Can Pre-Profit Space Stocks Deliver on $1.85B Backlog

Warren Buffett’s Parting Gift to Investors Is Crushing the Market 6 Months Later

'Convert $100,000 a Year to Get Them to the Top of the 22%': The Roth Plan for a Couple With $2.3M in 401(k)s

College-Educated Families Earned $242,200 While Others Made $42,200, Here's Why the Gap Widened

‘Convert $100,000 a Year to Get Them to the Top of the 22%’: The Roth Plan for a Couple With $2.3M in 401(k)s

UFO ETF Faces a Critical Test: Can Pre-Profit Space Stocks Deliver on $1.85B Backlog

Novartis : NVS

All Novartis Articles

Top Strategist Says Health Care Could Rule in 2022: 5 Dividend Winners

5 Top Goldman Sachs European Stock Picks Come With Big Dividends

5 European Dividend Aristocrats Offer Huge Income and Growth Potential

Monday’s Top Analyst Upgrades and Downgrades: Adobe, Analog Devices, Colgate, Novartis, Salesforce, Workday and More

4 Buy-Rated Giants Pay a Dividend of at Least 3%

DraftKings, H&R Block, Novartis and More Wednesday Afternoon Analyst Calls

Court Rejects Patent Protection, Crushing Amarin Stock

Big Pharma Advances on COVID-19

Top Analyst Upgrades and Downgrades: Aurora Cannabis, Biogen, Micron, Nio, Nvidia, Palo Alto, Tandem Diabetes, Tesla and More

5 Big Dividend Pharmaceutical Stocks to Buy as Health Care Could Explode Higher

Novartis Finally Comes Through With Its Acquisition of Medicines Co

Will Medicines Co Be the Next Target of Novartis?

Top Analyst Upgrades and Downgrades: DowDuPont, Electronic Arts, Estee Lauder, Exxon, Generac, Match, Nasdaq, Novartis, PayPal, Snap, Vishay and More

Why Tilray Is Booming

Top Analyst Upgrades and Downgrades: American Air, BlackBerry, Mallinkrodt, PG&E, RingCentral, Southwest Airlines, Yeti and More

‘Convert $100,000 a Year to Get Them to the Top of the 22%’: The Roth Plan for a Couple With $2.3M in 401(k)s

UFO ETF Faces a Critical Test: Can Pre-Profit Space Stocks Deliver on $1.85B Backlog

Warren Buffett’s Parting Gift to Investors Is Crushing the Market 6 Months Later

Featured Reads

'Convert $100,000 a Year to Get Them to the Top of the 22%': The Roth Plan for a Couple With $2.3M in 401(k)s

College-Educated Families Earned $242,200 While Others Made $42,200, Here's Why the Gap Widened